These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 34338773)

  • 1. Simultaneous Estimation of Six Nitrosamine Impurities in Valsartan Using Liquid Chromatographic Method.
    Bodiwala KB; Panchal BG; Savale SS; Dave JB; Sureja DK; Dhameliya TM; Chhabria MT
    J AOAC Int; 2022 Feb; 105(1):1-10. PubMed ID: 34338773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Multi-Analyte LC-MS/MS Method for Determination and Quantification of Six Nitrosamine Impurities in Sartans like Azilsartan, Valsartan, Telmisartan, Olmesartan, Losartan and Irbesartan.
    Gopireddy RR; Maruthapillai A; Mahapatra S
    J Chromatogr Sci; 2024 Feb; 62(2):147-167. PubMed ID: 35830866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of an analytical method for trace-level quantification of genotoxic nitrosamine impurities in losartan and hydrochlorothiazide fixed-dose combination tablets using ultra performance liquid chromatography triple quadrupole mass spectrometry.
    Patel R; Purohit S; Solanki R; Khunt D; Patel C; Patel R; Parikh S
    Rapid Commun Mass Spectrom; 2023 Apr; 37(8):e9488. PubMed ID: 36740827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new, rapid, stability-indicating UPLC method for separation and determination of impurities in amlodipine besylate, valsartan and hydrochlorothiazide in their combined tablet dosage form.
    Vojta J; Jedlička A; Coufal P; Janečková L
    J Pharm Biomed Anal; 2015 May; 109():36-44. PubMed ID: 25756663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous analysis of carcinogenic N-nitrosamine impurities in metformin tablets using on-line in-tube solid-phase microextraction coupled with liquid chromatography-tandem mass spectrometry.
    Ishizaki A; Ozawa K; Kataoka H
    J Chromatogr A; 2023 Nov; 1710():464416. PubMed ID: 37804578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid Quantitation of Four Nitrosamine Impurities in Angiotensin Receptor Blocker Drug Substances.
    Zhang J; Selaya SD; Shakleya D; Mohammad A; Faustino PJ
    J Pharm Sci; 2023 May; 112(5):1246-1254. PubMed ID: 36509171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous and trace level quantification of two potential genotoxic impurities in valsartan drug substance using UPLC-MS/MS.
    Li S; Dong L; Tang K; Lan Z; Liu R; Wang Y; Wang R; Lin H
    J Pharm Biomed Anal; 2022 Apr; 212():114630. PubMed ID: 35158183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High performance liquid chromatographic assay of amlodipine, valsartan and hydrochlorothiazide simultaneously and its application to pharmaceuticals, urine and plasma analysis.
    Shaikh JSA; Raut S; Abdul A; Pathan MAAK
    J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Oct; 1155():122295. PubMed ID: 32771968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A UPLC method development and validation study of Upadacitinib and its impurities in extended - release oral tablet dosage forms.
    Nimmagadda RL; Gummadi S
    Ann Pharm Fr; 2024 Sep; 82(5):780-791. PubMed ID: 38554818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a sensitive LC-APCI-MS/MS method for simultaneous determination of eleven nitrosamines in valsartan and irbesartan with a simple extraction approach.
    Mavis ME; Goksu Gursu G; Ular Cagatay N
    J Chromatogr B Analyt Technol Biomed Life Sci; 2023 Feb; 1216():123593. PubMed ID: 36669257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stability-indicating reversed-phase-HPLC method development and validation for sacubitril/valsartan complex in the presence of impurities and degradation products: Robustness by quality-by-design approach.
    Subramanian VB; Katari NK; Ponnam V; Konduru N; Dongala T; Marisetti VM; Vyas G
    Biomed Chromatogr; 2022 Jan; 36(1):e5240. PubMed ID: 34486750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and Validation of four Nitrosamine Impurities Determination Method in Medicines of Valsartan, Losartan, and Irbesartan with HPLC-MS/MS (APCI).
    Khorolskiy M; Ramenskaya G; Vlasov A; Perederyaev O; Maslennikova N
    Iran J Pharm Res; 2021; 20(3):541-552. PubMed ID: 34904007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous determination of 13 nitrosamine impurities in biological medicines using salting-out liquid-liquid extraction coupled with liquid chromatography tandem mass spectrometry.
    Luo F; Liu Y; Xie Y; Hou W; Zhang L; Zhang Z
    J Pharm Biomed Anal; 2022 Sep; 218():114867. PubMed ID: 35679708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of a stability-indicating, single HPLC method for sacubitril-valsartan and their stereoisomers and identification of forced degradation products using LC-MS/MS.
    Vijaykumar C; Kumar YR; Aparna P; Rao PSP
    Biomed Chromatogr; 2023 Feb; 37(2):e5550. PubMed ID: 36410774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-Performance Liquid Chromatography-Tandem Mass Spectrometry Method Development and Validation for Simultaneous Determination of Seven Nitrosamine and Azidomethyl-Biphenyl-Tetrazole Impurities in Losartan.
    Luan NM; Khuyen VTK; Tuan ND
    J Sep Sci; 2024 Oct; 47(19):e202400277. PubMed ID: 39385440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analytical Method Capable of Quantifying Eight Nitrosamine Impurities from Five Different Commercially Available Metformin Formulations with Glipizide, Glibenclamide, Gliclazide, Evogliptin, and Glimepiride by Ultra High Performance Liquid Chromatography Tripple Quadrupole Mass Spectrometry.
    Solanki R; Wadhwana P; Patel R; Gayakvad B; Kothari C; Patel C
    J Pharm Sci; 2023 May; 112(5):1268-1276. PubMed ID: 36822274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Practical and Science-Based Strategy for Establishing Acceptable Intakes for Drug Product
    Dobo KL; Kenyon MO; Dirat O; Engel M; Fleetwood A; Martin M; Mattano S; Musso A; McWilliams JC; Papanikolaou A; Parris P; Whritenour J; Yu S; Kalgutkar AS
    Chem Res Toxicol; 2022 Mar; 35(3):475-489. PubMed ID: 35212515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liquid chromatographic method for the simultaneous determination of achiral and chiral impurities of dapoxetine in approved and counterfeit products.
    Tóth G; Fogarasi E; Bartalis-Fábián Á; Foroughbakhshfasaei M; Boldizsár I; Darcsi A; Lohner S; Scriba GKE; Szabó ZI
    J Chromatogr A; 2020 Aug; 1626():461388. PubMed ID: 32797859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multianalyte LC-MS/MS method for accurate quantification of Nitrosamines in Olmesartan tablets.
    Pawar N; Bhardwaj A; Vora A; Sharma S
    J Chromatogr A; 2024 Sep; 1732():465176. PubMed ID: 39088899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and Validation of Two Novel Chromatographic Methods: HPTLC and HPLC for Determination of Bromhexine Hydrochloride in Presence of Its Two Impurities.
    Abdelwahab NS; Adly SM; Ali NW; Abdelrahman MM
    J Chromatogr Sci; 2021 Apr; 59(5):425-431. PubMed ID: 33532822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.